KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Inventory: 2009-2024

Historic Change in Inventory for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $20.9 million.

  • Pacira BioSciences' Change in Inventory rose 12.89% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year increase of 198.48%. This contributed to the annual value of $20.9 million for FY2024, which is 152.46% up from last year.
  • Latest data reveals that Pacira BioSciences reported Change in Inventory of $20.9 million as of FY2024, which was up 152.46% from $8.3 million recorded in FY2023.
  • Pacira BioSciences' Change in Inventory's 5-year high stood at $20.9 million during FY2024, with a 5-year trough of -$2.5 million in FY2022.
  • Over the past 3 years, Pacira BioSciences' median Change in Inventory value was $8.3 million (recorded in 2023), while the average stood at $8.9 million.
  • Per our database at Business Quant, Pacira BioSciences' Change in Inventory crashed by 155.65% in 2022 and then soared by 433.47% in 2023.
  • Yearly analysis of 5 years shows Pacira BioSciences' Change in Inventory stood at $6.4 million in 2020, then declined by 29.69% to $4.5 million in 2021, then tumbled by 155.65% to -$2.5 million in 2022, then spiked by 433.47% to $8.3 million in 2023, then skyrocketed by 152.46% to $20.9 million in 2024.